Clinical characteristics, antimicrobial susceptibility patterns, and treatment outcomes of nontuberculous mycobacterial diseases in eastern China: a retrospective cohort study (2019–2022)
Microbiology Spectrum · 06.01.2026 · 14 (1)
DOI: 10.1128/spectrum.01374-25 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Microbiology Spectrum, erschienen am 06.01.2026. Verfasst von Huijie Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tuberculosis Department, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Mycobacterium Infections, Nontuberculous, Anti-Bacterial Agents, Nontuberculous Mycobacteria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hangzhou Medical and Health Science and Technology Project, Key Project of Zhejiang Provincial Natural Science Foundation.
Abstract (Originalsprache)
Nontuberculous mycobacteria (NTM) are opportunistic pathogens, and the global incidence of NTM diseases has been steadily increasing, posing significant public health challenges. This study retrospectively analyzed clinical data from 136 cases of NTM disease diagnosed at the Zhejiang Provincial Tuberculosis Diagnosis and Treatment Center between 2019 and 2022. It was observed that NTM diseases in this region predominantly affected middle-aged and elderly men, with chronic cough being the principal symptom (74.3%). Bronchiectasis (57.4%) and cavities (38.2%) were the main imaging characteristics. The results of species identification demonstrated that Mycobacterium intracellulare (62.5%) was the dominant strain. Antimicrobial susceptibility testing revealed that Mycobacterium avium complex exhibited relatively favorable sensitivity to clarithromycin, amikacin, ethambutol, rifapentine, rifampicin, and moxifloxacin, while the Mycobacterium chelonae/Mycobacterium abscessus complex showed sensitivity only to amikacin (66.7%). In total, 66.2% of patients received anti-NTM therapy. Patients completing ≥6 months of treatment achieved significantly higher efficacy than those with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tuberculosis Department, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, Zhejiang, China.
- Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
ORCID-Profile: Qiang Zhan, Huaqiong Huang
Förderung
- Hangzhou Medical and Health Science and Technology Project
- Key Project of Zhejiang Provincial Natural Science Foundation
Zitieren
APA
Wang, H., Hua, H., Chen, Y., Zhan, Q., & Huang, H. (2026). Clinical characteristics, antimicrobial susceptibility patterns, and treatment outcomes of nontuberculous mycobacterial diseases in eastern China: a retrospective cohort study (2019–2022). Microbiology Spectrum, 14(1). https://doi.org/10.1128/spectrum.01374-25
Vancouver
Wang H, Hua H, Chen Y, Zhan Q, Huang H. Clinical characteristics, antimicrobial susceptibility patterns, and treatment outcomes of nontuberculous mycobacterial diseases in eastern China: a retrospective cohort study (2019–2022). Microbiology Spectrum. 2026;14(1). doi:10.1128/spectrum.01374-25
BibTeX
@article{Wang2026,
author = {Wang, Huijie and Hua, Haibo and Chen, Yuanyuan and Zhan, Qiang and Huang, Huaqiong},
title = {Clinical characteristics, antimicrobial susceptibility patterns, and treatment outcomes of nontuberculous mycobacterial diseases in eastern China: a retrospective cohort study (2019–2022)},
journal = {Microbiology Spectrum},
year = {2026},
volume = {14},
number = {1},
doi = {10.1128/spectrum.01374-25}
}
EUVIMED